Insider Shareholders with Direct Ownership of Deciphera Pharmaceuticals, Inc. (DCPH)
This section provides a comprehensive overview of the insiders with direct ownership of Deciphera Pharmaceuticals, Inc. (DCPH). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Deciphera Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Brightstar Associates Llc
> 10% Shareholder |
6,535,474 | 0 | 23,107,844 $0 | 5 |
Apr 22, 2024
Added 0.21%
|
|
Daniel Lee Flynn
Chief Scientific Officer |
59,188 | 9,070 | 57,158 $0 | 10 |
Jun 16, 2023
Reduced 2.81%
|
|
Dashyant Dhanak
EVP & Chief Scientific Officer |
184,088 | 184,088 | 0 $0 | 4 |
Jun 11, 2024
Reduced 100.0%
|
| 11,000 | 11,000 | 0 $0 | 2 |
Jun 11, 2024
Reduced 100.0%
|
|
| 52,241 | 52,241 | 0 $0 | 10 |
Apr 20, 2021
Reduced 100.0%
|
|
| 10,000 | 10,000 | 0 $0 | 2 |
Jun 11, 2024
Reduced 100.0%
|
|
|
Matthew L Sherman
EVP & Chief Medical Officer |
130,012 | 173,225 | 0 $0 | 25 |
Jun 11, 2024
Reduced 100.0%
|
|
Jama Pitman
SVP, Chief Development Officer |
84,158 | 101,598 | 0 $0 | 17 |
Jun 11, 2024
Reduced 100.0%
|
|
Daniel C. Martin
Chief Commercial Officer |
74,158 | 106,564 | 0 $0 | 18 |
Jun 11, 2024
Reduced 100.0%
|
|
Thomas Patrick Kelly
Chief Financial Officer |
127,108 | 134,148 | 0 $0 | 19 |
Jun 11, 2024
Reduced 100.0%
|
|
Steven L. Hoerter
President and CEO |
412,153 | 454,920 | 0 $0 | 11 |
Jun 11, 2024
Reduced 100.0%
|
|
Michael Douglas Taylor
Director |
233,315 | 233,315 | 0 $0 | 18 |
May 03, 2021
Reduced 100.0%
|